StonvexLoading…
StonvexStonvexStonvexCore line items from BMBL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $212.38M | $965.66M | $741.49M | $495.33M |
Operating Income | $65.25M | $-805.78M | $-230.03M | $-293.69M |
Net Income | $45.21M | $-693.14M | $-202.96M | $-240.30M |
EPS (Diluted) | $0.34 | $-5.95 | $-1.97 | $-2.31 |
Total Assets | $1.47B | $1.43B | $2.19B | $2.16B |
Total Liabilities | $737.66M | $743.97M | $1.16B | $1.16B |
Cash & Equivalents | $245.59M | $175.76M | $307.88M | $261.74M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 129.92M | 110.13M | 105.76M | 104.32M |